Biotechnology

BioSpecifics Technologies Corp. , a biopharmaceutical company developing first in class collagenase-based products, today announced that BioSpecifics' President, Thomas Wegman, will present at the upcoming Piper Jaffray 20th Annual Health Care Conference

Wyeth today announced that Michael Kamarck, Ph.D., 57, has been promoted to President, Technical Operations & Product Supply . Dr. Kamarck will be responsible for all aspects of technical operations and product supply for Wyeth, including its Pharmac

Total impact of NC's biotechnology sector is $45.8 billion, 180,007 jobs

Par Pharmaceutical Companies, Inc. today announced that the U.S. District Court for the District ofNew Jersey last night granted AstraZeneca Pharmaceuticals' motion for a temporary restraining order halting sales of Teva's generic Pulmicort Respules . In

At a meeting of the Board of Directors of Wyeth , held today, a dividend of fifty cents per share on the outstanding shares of Preferred Stock was declared payable on January 2, 2009 to stockholders of record at the close of business on December 12, 2008

Aastrom Biosciences, Inc. , a leading regenerative medicine company, today announced that the first patient has been treated in its randomized, controlled, prospective, open-label IMPACT-DCM clinical trial. Currently enrolling patients at The Methodist H

Neurocrine Biosciences, Inc. announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences will be presenting at the 20th Annual Piper Jaffray Health Care Conference inNew York.

Nephros, Inc. , a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, today provided an update on its operations and strategy.